Beigene Btki News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Beigene Btki. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Beigene Btki Today - Breaking & Trending Today

BeiGene, Ltd.: BRUKINSA Approved in Canada for the Treatment of Chronic Lymphocytic Leukemia

Published: May 30, 2023

BeiGene's BTKi is approved in more than 65 markets globally BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, announced today that BRUKINSA (zanubrutinib), a

Source: finanznachrichten.de

Related Topics:

United StatesSouth KoreaUnited KingdomGreat BritainMehrdad MobasherKevin MannixKyle BlankenshipChristine ChenRaymond VlesBeigene BtkiExchange CommissionHealth CanadaBeigene LtdEuropean UnionPrincess Margaret Cancer CentreChief Medical OfficerClinician InvestigatorPrincess Margaret CancerAmerican SocietyHematology Annual MeetingThenew England JournalLancet OncologyBoard ChairLooking StatementsPrivate Securities Litigation Reform Act